Dr. Nate Lighthizer advises ODs to embrace management of eye diseases such as dry eye and glaucoma. Here are his tips for building a diverse, healthy optometry practice.
SLT Is my Patients “Insurance Policy” COVID-19 just Proved it
With Selecta Duet, Dr. Nate Radcliffe controls IOP without frequent visits and often without medication—two clear advantages during COVID-19 lockdowns.
SLT for Glaucoma with Dr. Nate Lighthizer
In an interactive webinar, Dr. Nate Lighthizer discusses Lumenis SLT’s advantages for glaucoma patients and referral decisions for this trusted laser treatment.
The dropless future: SLT as a first-line treatment for glaucoma
Dr. Kristin O. Chapman explains how SLT’s promotion to first-line therapy is changing the age-old battle for glaucoma drop tolerance and adherence.
Ge et al. (2020): Evaluation of the efficacy of optimal pulsed technology treatment in patients with cataract and Meibomian gland dysfunction in the perioperative period
In a prospective, comparative study, Lumenis IPL with OPT™ improved signs and symptoms of mild to moderate MGD in patients who underwent cataract surgery.
Determining where thermal pulsation + IPL therapy meet
Thermal pulsation clears meibum, while IPL break the dry eye vicious cycle of inflammation. Dr. Cynthia Matossian shares her protocol for choosing one or both procedures.
Dry eyes and the postoperative patient
Treating surgical patients’ dry eye requires a team approach, according to Dr. Shilpa Rose, who explains her approach after a range of procedures such as OptiLight.
Using IPL to treat glaucoma patients with dry eye disease
Glaucoma specialist Dr. Steven Vold shares how Lumenis IPL with OPT™ changes his patients’ lives by improving their comfort and tolerance of topical medications.
Implementing IPL into a OD Practice
Dr. Doug Devries details how OptiLight therapy is tailor-made for optometry and shares his advice for bringing the technology into an OD practice.
Fishman et al (2020): Real-Time Video Microscopy of In Vitro Demodex Death by Intense Pulsed Light
An in-vitro study demonstrated that, with settings used for treatment of dry eye due to meibomian gland dysfunction (MGD), Lumenis IPL with OPTTM destroyed an isolated Demodex mite.